P1.03-010 Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.814 ◽

2017 ◽

Vol 12 (11) ◽

pp. S1954

Author(s):

R. Imase ◽

S. Endo ◽

Y. Sasahara ◽

T. Shinmura ◽

T. Ozawa ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

PD2.04 Long Term Efficacy and Safety of Ensartinib in Pre-Treated Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients (eXalt2)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.09.131 ◽

2019 ◽

Vol 14 (11) ◽

pp. S1171-S1172

Author(s):

T. Leal ◽

H. Wakelee ◽

K.L. Reckamp ◽

A. Chiappori ◽

G.R. Oxnard ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Download Full-text

Editorial on the article entitled “brigatinib efficacy and safety in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in a phase I/II trial”

Journal of Thoracic Disease ◽

10.21037/jtd.2016.10.57 ◽

2016 ◽

Vol 8 (10) ◽

pp. E1287-E1292 ◽

Author(s):

Ivana Sullivan ◽

David Planchard

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Brigatinib (BRG) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC): Long-term efficacy and safety results from a phase 1/2 trial

Annals of Oncology ◽

10.1093/annonc/mdx380.046 ◽

2017 ◽

Vol 28 ◽

pp. v479-v480 ◽

Author(s):

L.A. Bazhenova ◽

S.N. Gettinger ◽

C.J. Langer ◽

R. Salgia ◽

K.A. Gold ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Phase 1 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

An interaction map of small-molecule kinase inhibitors with anaplastic lymphoma kinase (ALK) mutants in ALK-positive non-small cell lung cancer

Biochimie ◽

10.1016/j.biochi.2015.03.003 ◽

2015 ◽

Vol 112 ◽

pp. 111-120 ◽

Author(s):

Xinghao Ai ◽

Shengping Shen ◽

Lan Shen ◽

Shun Lu

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Molecule ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Interaction Map ◽

Download Full-text

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2018.10.23 ◽

2018 ◽

Vol 8 (S1) ◽

pp. S48-S54

Author(s):

Tiziana Vavalà ◽

Annapaola Mariniello ◽

Silvia Novello

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non‑small cell lung cancer (Review)

Oncology Reports ◽

10.3892/or.2020.7851 ◽

2020 ◽

Author(s):

Li Wang ◽

Wen Wang

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Anaplastic Lymphoma ◽

Download Full-text

Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer

Precision Cancer Medicine ◽

10.21037/pcm.2019.12.04 ◽

2020 ◽

Vol 3 ◽

pp. 3-3

Author(s):

Yasuhiro Chikaishi ◽

Kenichi Kobayashi ◽

Hiroki Matsumiya ◽

Akihiro Taira ◽

Yusuke Nabe ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitors ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Kinase Inhibitors ◽

Small Cell Lung ◽

Anaplastic Lymphoma

Download Full-text

1330: Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(16)30245-3 ◽

2016 ◽

Vol 11 (4) ◽

pp. S114 ◽

Author(s):

R. Rosell ◽

S.N. Gettinger ◽

L.A. Bazhenova ◽

C.J. Langer ◽

R. Salgia ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Phase 1 ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Download Full-text

Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct04009317 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Line Treatment ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Visual Effects in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib

Annals of Oncology ◽

10.1016/s0923-7534(20)32041-x ◽

2012 ◽

Vol 23 ◽

pp. xi44

Author(s):

P.-C. Yang ◽

R. Salgia ◽

B. Solomon ◽

A.T. Shaw ◽

D.R. Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell Lung ◽

Visual Effects ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Download Full-text